Financhill
Back

Revance Therapeutics Stock Price Chart

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
13

RVNC
Revance Therapeutics

Last Price:
3.71
Seasonality Move:
7.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight selling pressure.

Revance Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.57 Sell
20-day SMA: 5.42 Sell
50-day SMA: 5.69 Sell
200-day SMA: 4.68 Sell
8-day EMA: 5.3 Sell
20-day EMA: 5.44 Sell
50-day EMA: 5.41 Sell
200-day EMA: 6.23 Sell

Revance Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 23.76 Sell
Chaikin Money Flow: -6197363 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.92 - 5.86) Sell
Bollinger Bands (100): (3.46 - 6.32) Sell

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Revance Therapeutics Stock

Is Revance Therapeutics Stock a Buy?

RVNC Technical Analysis vs Fundamental Analysis

Sell
13
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy or a Sell?

Revance Therapeutics Stock Info

Market Cap:
385.99M
Price in USD:
3.71
Share Volume:
12.96M

Revance Therapeutics 52-Week Range

52-Week High:
9.75
52-Week Low:
2.30
Sell
13
Revance Therapeutics (RVNC) is a Sell

Revance Therapeutics Share Price Forecast

Is Revance Therapeutics Stock a Buy?

Fundamental Analysis of Revance Therapeutics

Is Revance Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.

Technical Analysis of Revance Therapeutics

Should I short Revance Therapeutics stock?

* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.